Clearpoint Neuro Inc expected to post a loss of 31 cents a share - Earnings Preview

What happened

Clearpoint Neuro Inc is expected to report a 38.8% rise in quarterly revenue to $12.3 million, up from $8.86 million a year ago, when it reports results on October 28 for the period ending September 30 2026, according to two analysts.

Confirmed

Global impact / market context

Analysts expect revenue growth but still forecast a loss of 31 cents per share, which means the company may be spending heavily to grow. Investors will compare actual results with these estimates to judge whether the strong buy rating and $23.50 median price target hold up.

Analyst inference

The median 12-month price target of $23.50 sits about 157.1% above the last closing price of $9.14, suggesting analysts see large potential upside. All two covering analysts rate the shares strong buy or buy, with no hold or sell ratings, and earnings estimates were unchanged over three months.

Analyst inference

What to watch

1. Watch whether reported revenue reaches the $12.3 million mean estimate from two analysts, compared with $8.86 million a year earlier. Confirmed
2. Watch whether the company reports a loss of 31 cents per share as estimated, since a wider loss could challenge the strong buy ratings. Proposed
3. Watch whether updated analyst ratings or the $23.50 median price target change after earnings, since no hold or sell ratings currently exist. Analyst inference

Affected assets

• SOL — Solana

Evidence

• Original source link unavailable